Long-term Outcomes of Chemoradiation for Muscle-invasive Bladder Cancer in Noncystectomy Candidates. Final Results of NRG Oncology RTOG 0524—A Phase 1/2 Trial of Paclitaxel + Trastuzumab with Daily Radiation or Paclitaxel Alone with Daily Irradiation

Autor: Dahl, Douglas M., Karrison, Theodore G., Michaelson, M. Dror, Pham, Huong T., Wu, Chin-Lee, Swanson, Gregory P., Shipley, William U., Vuky, Jacqueline, Lee, R. Jeffrey, Zietman, Anthony L., Souhami, Luis, Chang, Brian K., Deming, Richard L., Ellerton, John A., Sandler, Howard M., Rodgers, Joseph P., Feng, Felix Y., Efstathiou, Jason A.
Zdroj: In European Urology Oncology February 2024 7(1):83-90
Databáze: ScienceDirect
Externí odkaz: